Treatment Overview

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 184 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Alzheimer's Biomarkers: Overview of Existing and Future Biomarkers. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Alzheimer's Biomarkers: Overview of Existing and Future Biomarkers (online CE course)
Treatment Overview

Because AD is a complex disease, it is difficult to treat and it is unlikely that any one drug or other type of therapy will be successful in treating the disease. Current treatment is centered on the maintenance of mental functions combined with the management and control of behavioral symptoms of AD. There are several prescription drugs approved by the FDA to treat individuals with AD. Most drugs tend to be more effective for individuals in the early or middle stages of AD. Although none of these medicines will stop the disease, they can slow down the various symptoms for a period of time. In doing so, a drug intervention may offer the Alzheimer's patient additional comfort and independence for a longer period of time and provide more assistance for caregivers.